Research Article
BibTex RIS Cite

Akciğer Kanseri Semptom Taramasının Sigara Bıraktırmadaki Rolü

Year 2022, Volume: 12 Issue: 1, 52 - 57, 14.01.2022
https://doi.org/10.33631/sabd.1055261

Abstract

Amaç: Bu çalışmada Düzce ilinde 30 yaş ve üzeri sigara içenlerde akciğer kanseri semptom taramasının sigara bırakmadaki rolü araştırıldı.
Gereç ve Yöntemler: Randomize 700 hane seçilerek 30 yaş üzeri sigara anamnezi olan 500 olgu çalışmaya alındı. Olguların sigara alışkanlıkları ve akciğer kanseri semptomları bir anket formuyla yüz yüze görüşmeyle sorgulandı. Sigaranın akciğer kanseri için önemli bir risk faktörü olduğu vurgulandı. Halen aktif sigara içen 474 olgunun 353'üne 6 ay sonra telefonla sigara alışkanlıkları yeniden sorgulandı.
Bulgular: Toplam 353 sigara içen olgunun 32’si (%9,1) kadın, 321’i (%90,9) erkekti. Yaş ortalaması 46±9 olan olguların, ortalama 36±24 paket-yıl sigara anamnezi vardı. 130'u (%36,8) sigarayı bırakmayı düşünüyordu ve 65'i (%18,4) sigarayı bırakmayı denemişti. 6 ay sonraki kontrolde 17 olgu (%4,8) sigarayı bırakmış, 59 olgu (%16) sigarayı azaltmış, 2 olgu (%0,6) ise artırmıştı. Sigarayı bırakanların hiçbiri ilk görüşmede bırakmayı düşündüğünü söyleyenler veya daha önce bırakmayı deneyenlerden değildi. Sigarayı bırakanların yaş ortalaması sigara içmeye devam edenlere göre daha yüksekti (p=0,044) ve sigarayı bırakanların daha uzun süredir sigara içme öyküleri vardı (p=0,001). Hemoptizi ve çomak parmak semptomlarının varlığı sigara bırakma oranlarını anlamlı düzeyde artırmaktaydı (sırasıyla p=0,048, p=0,013). Bu çalışmada akciğer kanseri semptom sorgulamasından 6 ay sonraki sigara bırakma oranı (%4,8), kendiliğinden sigarayı bırakma oranından (%1) anlamlı düzeyde yüksekti (p=0,001).
Sonuç: Akciğer kanseri semptom taramasıyla sigara bırakma oranları artırılabilir. Sigara bırakma poliklinikleri yanında bu tip yaklaşımlar sigara mücadelesine katkıda bulunabilir.

References

  • WHO report on the global tobacco epidemic, 2017. World Health Organization 2017.
  • Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin. 2013; 23(2): 103-12. https://doi.org/10.1016/j.thorsurg.2013.01.009.
  • Akdur R, Soydal T. Uluslalarası katılımlı üçüncü sigara ve sağlık ulusal kongresi bildirisi. Tütünsüz Yaşam Dergisi. 2006; 2: 1-3.
  • Türk Toplumunda Sigara İçme Davranışları ve Sigara İçme ve Sigara Karşıtı Kampanyalara Karşı Tutumlar. TC Sağlık Bakanlığı Raporu. PİAR. Ocak 1988.
  • Blok DJ, de Vlas SJ, van Empelen P, van Lenthe FJ. The role of smoking in social networks on smoking cessation and relapse among adults: A longitudinal study. Prev Med. 2017; 99: 105-10. https://doi.org/10.1016/j.ypmed.2017.02.012.
  • Tütün Kullanımında Global Trendler. Sigara İçmenin Sağlık Üzerindeki Sonuçları, Salgını Durdurmak. Yönetimler ve Tütün Kontrolünün Ekonomisi. Dünya Bankası Yayını. Çev. Taş Ş. İstanbul Yüce Reklam Yayım Dağıtım A.Ş; 2000: 1-28.
  • Jackson G, Bobak A, Chorlton I. Smoking cessation: A consensus statement with special reference to primary care. Int J Clin Pract. 2001; 55: 385-92.
  • Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013: 31; 2013(5): CD000165. https://doi.org/10.1002/14651858.pub4.
  • Risser NL, Belcher DW. Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trial. J Gen Intern Med. 1990; 5: 16-22.
  • Balbay Ö, Annakkaya AN, Arbak P, Erbaş M, Bilgin C. Do clinic and chest X-ray findings of patients effect treatment compliance?. Proceedings of the ERS Annual Congress; 2002 Sep14-18; Sweden, 2002; 20 (38). p. 547.
  • Hepper NG, Drage CW, Davies SF, Rupp WM, LaMothe J, Schoenfelder PG, et al. Chronic obstructive pulmonary disease: a community-oriented program including professional education and screening by a voluntary health agency. Am Rev Respir Dis. 1980; 121(1): 97-104.
  • Townsend CO, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005; 103(10): 2154-62.
  • Schwartz JL. Review and evaluation of smoking cessation methods: The United States and Canada 1978 – 1985, Public Health Service, National Cancer Institute. NIH Publication No. 87-2940, 1087.
  • Livingstone-Banks J, Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No.: CD003999. https://doi.org/ 10.1002/14651858.CD003999.pub5.
  • Özmen K, Dumlu T, Arbak P, Balbay Ö, Annakkaya AN. Astım, KOAH ve akciğer kanseri hastalarında ve refakatçilerinde sigara alışkanlığı. Türkiye Solunum Araştırmaları Derneği 30. Ulusal Kongresi; 2008 Ekim 26-30; Bodrum, Muğla.
  • Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following ct screening for early detection of lung cancer. Prev Med. 2001; 33(6): 613-21.
  • Jamrozik K, Vessey M, Fowler G, Wald N, Parker G,Van Vunakis H. Controlled trial of three different antismoking interventions in general practice. BMJ. 1984: 19; 288(6429): 1499-503.
  • Buffels J, Degryse J, Decramer M, Heyrman J. Spirometry and smoking cessation advice in general practice: A randomized clinical trial. Respir Med. 2006; 100(11): 2012-7.
  • Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial Evaluation of the patient with lung cancer. Symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest. 2003; 123: 97-104.
  • European Medical Association Smoking or Health (EMASH): Guidelines on smoking cessation for general practitioners and other health professionals. Monaldi Arch Chest Dis. 1997; 52: 282-4.
  • Smoking and health: physician responsibility. A statement of the Joint Committee on Smoking and Health. American College of Chest Physicians. American Thoracic Society. Asia Pacific Society of Respirology. Canadian Thoracic Society. European Respiratory Society, and International Union Against Tuberculosis and Lung Disease. Chest. 1995; 108(4): 1118-21.
  • Tillgren P, Haglund BJ, Lundberg M, Romelsjo A. The sociodemographic pattern of tobacco cessation in the 980s: results from a panel study of living condition surveys in Sweden. J Epidemiol Community Health. 1996; 50: 625-30.
  • Fernandez E, Garcia M, Schiaffi A, Borras JM, Nebot M, Segura A. Smoking initiation and cessation by gender and educational level in catolina, Spain. Prev Med. 2001; 32: 218-23.
  • Balbay Ö, Annakkaya AN, Aytar G, Bilgin C. Düzce tıp fakültesi göğüs hastalıkları sigara bırakma polikliniği sonuçları. Düzce Tıp Fakültesi Derg. 2003; 3: 10-4.

The Role of Lung Cancer Symptom Screening in Smoking Cessation

Year 2022, Volume: 12 Issue: 1, 52 - 57, 14.01.2022
https://doi.org/10.33631/sabd.1055261

Abstract

Aim: In this study, the role of lung cancer symptom screening in smokers aged 30 and over in Duzce city was investigated.
Materials and Methods: 500 cases over 30 years of age with a smoking history randomly selected from 700 households were included in the study. The smoking habits and symptoms of lung cancer cases were evaluated by a questionnaire with a face to face manner. It was emphasized that smoking is an important risk factor for lung cancer. Smoking habits were re-questioned by phone in 353 of 474 active smokers 6 months later.
Results: Of the 353 smokers, 32 (9.1%) were female and 321 (90.9%) were male. It consisted of cases with a mean age of 46±9 and an average of 36±24 pack/year smoking history. 130 cases (%36.8) were intended to smoking cessation and 65 (%18,4) had tried smoking cessation. In the 6 months follow-up 17 (%4.8) of them had given up smoking, 59 (%16) of them had decreased, and 2 (%0,6) of them had increased it. The cases who had given up smoking were not the ones who had an intention to smoking cessation and had tried to quit at the first interview. Those who quit smoking had a higher mean age (p=0.044) and had a longer smoking history (p=0.001). The presence of hemoptysis and clubbing symptoms significantly increased smoking cessation rates (p=0.048, p=0.013, respectively). In this study, the quit rate after 6 months of lung cancer symptom questioning (4.8%) was significantly higher than the spontaneous smoking cessation rate (1%) (p=0.001).
Conclusion: Smoking cessation rates can be increased by screening for lung cancer symptoms. Along with smoking cessation outpatient clinics, such approaches can contribute to the fight against smoking.

References

  • WHO report on the global tobacco epidemic, 2017. World Health Organization 2017.
  • Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin. 2013; 23(2): 103-12. https://doi.org/10.1016/j.thorsurg.2013.01.009.
  • Akdur R, Soydal T. Uluslalarası katılımlı üçüncü sigara ve sağlık ulusal kongresi bildirisi. Tütünsüz Yaşam Dergisi. 2006; 2: 1-3.
  • Türk Toplumunda Sigara İçme Davranışları ve Sigara İçme ve Sigara Karşıtı Kampanyalara Karşı Tutumlar. TC Sağlık Bakanlığı Raporu. PİAR. Ocak 1988.
  • Blok DJ, de Vlas SJ, van Empelen P, van Lenthe FJ. The role of smoking in social networks on smoking cessation and relapse among adults: A longitudinal study. Prev Med. 2017; 99: 105-10. https://doi.org/10.1016/j.ypmed.2017.02.012.
  • Tütün Kullanımında Global Trendler. Sigara İçmenin Sağlık Üzerindeki Sonuçları, Salgını Durdurmak. Yönetimler ve Tütün Kontrolünün Ekonomisi. Dünya Bankası Yayını. Çev. Taş Ş. İstanbul Yüce Reklam Yayım Dağıtım A.Ş; 2000: 1-28.
  • Jackson G, Bobak A, Chorlton I. Smoking cessation: A consensus statement with special reference to primary care. Int J Clin Pract. 2001; 55: 385-92.
  • Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013: 31; 2013(5): CD000165. https://doi.org/10.1002/14651858.pub4.
  • Risser NL, Belcher DW. Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: a randomized trial. J Gen Intern Med. 1990; 5: 16-22.
  • Balbay Ö, Annakkaya AN, Arbak P, Erbaş M, Bilgin C. Do clinic and chest X-ray findings of patients effect treatment compliance?. Proceedings of the ERS Annual Congress; 2002 Sep14-18; Sweden, 2002; 20 (38). p. 547.
  • Hepper NG, Drage CW, Davies SF, Rupp WM, LaMothe J, Schoenfelder PG, et al. Chronic obstructive pulmonary disease: a community-oriented program including professional education and screening by a voluntary health agency. Am Rev Respir Dis. 1980; 121(1): 97-104.
  • Townsend CO, Clark MM, Jett JR, Patten CA, Schroeder DR, Nirelli LM, et al. Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screening. Cancer. 2005; 103(10): 2154-62.
  • Schwartz JL. Review and evaluation of smoking cessation methods: The United States and Canada 1978 – 1985, Public Health Service, National Cancer Institute. NIH Publication No. 87-2940, 1087.
  • Livingstone-Banks J, Relapse prevention interventions for smoking cessation. Cochrane Database of Systematic Reviews 2019, Issue 2. Art. No.: CD003999. https://doi.org/ 10.1002/14651858.CD003999.pub5.
  • Özmen K, Dumlu T, Arbak P, Balbay Ö, Annakkaya AN. Astım, KOAH ve akciğer kanseri hastalarında ve refakatçilerinde sigara alışkanlığı. Türkiye Solunum Araştırmaları Derneği 30. Ulusal Kongresi; 2008 Ekim 26-30; Bodrum, Muğla.
  • Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following ct screening for early detection of lung cancer. Prev Med. 2001; 33(6): 613-21.
  • Jamrozik K, Vessey M, Fowler G, Wald N, Parker G,Van Vunakis H. Controlled trial of three different antismoking interventions in general practice. BMJ. 1984: 19; 288(6429): 1499-503.
  • Buffels J, Degryse J, Decramer M, Heyrman J. Spirometry and smoking cessation advice in general practice: A randomized clinical trial. Respir Med. 2006; 100(11): 2012-7.
  • Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial Evaluation of the patient with lung cancer. Symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest. 2003; 123: 97-104.
  • European Medical Association Smoking or Health (EMASH): Guidelines on smoking cessation for general practitioners and other health professionals. Monaldi Arch Chest Dis. 1997; 52: 282-4.
  • Smoking and health: physician responsibility. A statement of the Joint Committee on Smoking and Health. American College of Chest Physicians. American Thoracic Society. Asia Pacific Society of Respirology. Canadian Thoracic Society. European Respiratory Society, and International Union Against Tuberculosis and Lung Disease. Chest. 1995; 108(4): 1118-21.
  • Tillgren P, Haglund BJ, Lundberg M, Romelsjo A. The sociodemographic pattern of tobacco cessation in the 980s: results from a panel study of living condition surveys in Sweden. J Epidemiol Community Health. 1996; 50: 625-30.
  • Fernandez E, Garcia M, Schiaffi A, Borras JM, Nebot M, Segura A. Smoking initiation and cessation by gender and educational level in catolina, Spain. Prev Med. 2001; 32: 218-23.
  • Balbay Ö, Annakkaya AN, Aytar G, Bilgin C. Düzce tıp fakültesi göğüs hastalıkları sigara bırakma polikliniği sonuçları. Düzce Tıp Fakültesi Derg. 2003; 3: 10-4.
There are 24 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Research Articles
Authors

Reşat Yeşiloğlu This is me 0000-0001-8959-2847

Ali Nihat Annakkaya This is me 0000-0002-7661-8830

Nevin Kalkanlı This is me 0000-0001-6246-2524

Naciye Karataş This is me 0000-0002-2134-8853

Öner Balbay This is me 0000-0002-7413-1367

Peri Arbak This is me 0000-0001-5730-0790

Publication Date January 14, 2022
Submission Date April 12, 2021
Published in Issue Year 2022 Volume: 12 Issue: 1

Cite

Vancouver Yeşiloğlu R, Annakkaya AN, Kalkanlı N, Karataş N, Balbay Ö, Arbak P. Akciğer Kanseri Semptom Taramasının Sigara Bıraktırmadaki Rolü. VHS. 2022;12(1):52-7.